Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pearson

Showing results (1161-1170 of 1,239) with videos related to

Pageof 124
Sort By:
Cancer Research|June 30, 2020
Noninvasive MRI Native T<sub>1</sub> Mapping Detects Response to <i>MYCN</i>-targeted Therapies in the Th-<i>MYCN</i> Model of NeuroblastomaKonstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Physical Review Letters|February 7, 2007
Measurement of the cascade transition via the first excited state of 16O in the 12C(alpha,gamma)16O reaction, and its S factor in stellar helium burningC Matei, L Buchmann, W R Hannes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK studyLucas Moreno, Lynley V Marshall, Andrew D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group StudyGareth J Veal, Michael Cole, Julie Errington, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
SARS-CoV-2 membrane protein biogenesisJuan Ortiz-Mateu, Guy J Pearson, Marina Rius-Salvador, et al.
The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
Monthly Notices of the Royal Astronomical Society|November 12, 2019
The C-Band All-Sky Survey (C-BASS): Simulated parametric fitting in single pixels in total intensity and polarizationLuke Jew, Angela C Taylor, Michael E Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Pageof 124

Showing results (1161-1170 of 1,239) with videos related to

Sort By:
Pageof 124
Cancer Research|June 30, 2020
Noninvasive MRI Native T<sub>1</sub> Mapping Detects Response to <i>MYCN</i>-targeted Therapies in the Th-<i>MYCN</i> Model of NeuroblastomaKonstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Physical Review Letters|February 7, 2007
Measurement of the cascade transition via the first excited state of 16O in the 12C(alpha,gamma)16O reaction, and its S factor in stellar helium burningC Matei, L Buchmann, W R Hannes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK studyLucas Moreno, Lynley V Marshall, Andrew D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group StudyGareth J Veal, Michael Cole, Julie Errington, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
SARS-CoV-2 membrane protein biogenesisJuan Ortiz-Mateu, Guy J Pearson, Marina Rius-Salvador, et al.
The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
Monthly Notices of the Royal Astronomical Society|November 12, 2019
The C-Band All-Sky Survey (C-BASS): Simulated parametric fitting in single pixels in total intensity and polarizationLuke Jew, Angela C Taylor, Michael E Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Pageof 124